Premier sent a letter outlining recommended actions CMS can take immediately to address challenges that long-term care pharmacy (LTCP) and infusion pharmacy providers are facing in the face of the COVID-19 epidemic.
On behalf of LTCP, Premier urged CMS to:
- Provide flexibilities concerning the DRR requirements so that pharmacists and pharmacy personnel may collaborate with facilities on the best methods to continue to provide these required services to residents.
- Provide uniform guidance on Part D point-of-sale edits to override: prior authorizations, formulary interchange, and refill- too-soon requirements.
- Waive the short-cycle dispensing requirements and provide guidance to plans directing them to suspend any policies, practices or procedures that deny coverage based on short-cycle dispensing requirements.
On behalf of home infusion pharmacies, Premier urged CMS to:
- Relax proof of delivery signature requirements for all home infusion drugs.
- Provide proper reimbursement for the services associated with all infusion drugs delivered in the home each day the drug is infused.